SoftOx Solutions AS (OSL:SOFTX)

Norway flag Norway · Delayed Price · Currency is NOK
0.0406
+0.0042 (11.54%)
At close: Mar 28, 2025
-90.98%
Market Cap 90.96M
Revenue (ttm) 7.91M
Net Income (ttm) -50.46M
Shares Out 2.24B
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 57,180,160
Average Volume 67,931,181
Open 0.0380
Previous Close 0.0364
Day's Range 0.0352 - 0.0470
52-Week Range 0.0100 - 2.7800
Beta -1.89
RSI 52.28
Earnings Date Mar 5, 2025

About SoftOx Solutions AS

SoftOx Solutions AS, together with its subsidiaries, operates as a medtech and clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. Its products include SafeDes+, a hand disinfectant for irritated, compromised, and eczematous skin; and EffectDesH, a surface disinfectant, which has a killing/inactivation effect on bacteria, viruses, yeast, fungi, mycobacterium, and spores. The company also provides human wound and infection treatment products comprising SoftOx Wound Irrigat... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 7
Stock Exchange Oslo Børs
Ticker Symbol SOFTX
Full Company Profile

Financial Performance

In 2024, SoftOx Solutions AS's revenue was 7.91 million, an increase of 13.38% compared to the previous year's 6.98 million. Losses were -50.46 million, 27.9% more than in 2023.

Financial Statements

News

There is no news available yet.